Adipic Acid

Adipic Acid

SCHEMBL749775

CC=C(O)O.O=C(O)CCCCC(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC18A2SLC6A2SLC6A3

The experimentally established mechanism targets of Adipic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.69
TSHR P16473 5/20 0.65
NFKB1 P19838 1/20 0.65
PMP22 Q01453 1/20 0.65
AKR1B1 P15121 1/20 0.60
SLC22A6 Q4U2R8 2/20 0.59
GPR84 Q9NQS5 8/20 0.57
PPARG P37231 7/20 0.57
PPARD Q03181 7/20 0.57
PPARA Q07869 7/20 0.57
HDAC11 Q96DB2 5/20 0.57
PTPN1 P18031 3/20 0.57
ALDH1A1 P00352 2/20 0.57
TLR2 O60603 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
FABP4 P15090 2/20 0.57
FFAR1 O14842 2/20 0.57
FFAR4 Q5NUL3 2/20 0.57
SLC22A8 Q8TCC7 1/20 0.57
MEN1 O00255 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adipic Acid SCHEMBL6550913 0.88 LMNA (0.69) LMNATSHRNFKB1PMP22AKR1B1
Sebacic Acid SCHEMBL28243888 0.88 TSHR (0.75) LMNATSHRNFKB1PMP22AKR1B1
Adipic Acid SCHEMBL6550920 0.88 LMNA (0.69) LMNATSHRNFKB1PMP22AKR1B1
Adipic Acid SCHEMBL6552701 0.88 LMNA (0.69) LMNATSHRNFKB1PMP22AKR1B1
Adipic Acid SCHEMBL23533535 0.85 LMNA (0.65) LMNATSHRNFKB1PMP22AKR1B1
Sebacic Acid SCHEMBL6551847 0.85 TSHR (0.71) LMNATSHRNFKB1PMP22AKR1B1
Adipic Acid SCHEMBL27845078 0.85 LMNA (0.65) LMNATSHRNFKB1PMP22AKR1B1
Adipic Acid SCHEMBL27756650 0.85 LMNA (0.65) LMNATSHRNFKB1PMP22AKR1B1
Adipic Acid SCHEMBL6402459 0.85 LMNA (0.65) LMNATSHRNFKB1PMP22AKR1B1
Adipic Acid SCHEMBL874846 0.85 LMNA (0.65) LMNATSHRNFKB1PMP22AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11160734-B2 Personal care compositions comprising shaped abrasive particles THE PROCTER & GAMBLE COMPANY (US) 2021-11-02 US disclosed
EP-2720666-B1 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES PROCTER & GAMBLE (US) 2019-03-20 EP disclosed
US-20170312190-A1 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES PROCTER & GAMBLE (US) 2017-11-02 US disclosed
US-9675531-B2 Personal care compositions comprising shaped abrasive particles THE PROCTER & GAMBLE COMPANY (US) 2017-06-13 US disclosed
US-8759270-B2 Liquid detergent composition with abrasive particles THE PROCTER & GAMBLE COMPANY (US) 2014-06-24 US disclosed
EP-2720666-A2 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES The Procter and Gamble Company (US) 2014-04-23 EP disclosed
US-8546316-B2 Liquid detergent composition with natural abrasive particles THE PROCTER & GAMBLE COMPANY (US) 2013-10-01 US disclosed
EP-2561055-A1 LIQUID CLEANING AND/OR CLEANSING COMPOSITION The Procter & Gamble Company (US) 2013-02-27 EP disclosed
EP-2561056-A1 LIQUID CLEANING AND/OR CLEANSING COMPOSITION The Procter & Gamble Company (US) 2013-02-27 EP disclosed
US-20130039961-A1 Personal Care Compositions Comprising Shaped Abrasive Particles THE PROCTER & GAMBLE COMPANY 2013-02-14 US disclosed
WO-2012177629-A2 LIQUID DETERGENT COMPOSITION WITH ABRASIVE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2012-12-27 WO disclosed
EP-2537917-A1 Liquid detergent composition with abrasive particles The Procter & Gamble Company (US) 2012-12-26 EP disclosed
US-20120322713-A1 LIQUID DETERGENT COMPOSITION WITH ABRASIVE PARTICLES THE PROCTER & GAMBLE COMPANY 2012-12-20 US disclosed
WO-2012040314-A1 LIQUID DETERGENT COMPOSITION WITH ABRASIVE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2012-03-29 WO disclosed
US-20120071383-A1 LIQUID DETERGENT COMPOSITION WITH ABRASIVE PARTICLES THE PROCTER & GAMBLE COMPANY 2012-03-22 US disclosed
EP-2431451-A1 Liquid detergent composition with abrasive particles The Procter & Gamble Company (US) 2012-03-21 EP disclosed
WO-2011133438-A1 LIQUID CLEANING AND/OR CLEANSING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2011-10-27 WO disclosed
WO-2011133508-A1 LIQUID CLEANING AND/OR CLEANSING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2011-10-27 WO disclosed
US-20110262504-A1 LIQUID CLEANING AND/OR CLEANSING COMPOSITION THE PROCTER & GAMBLE COMPANY 2011-10-27 US disclosed
US-20110262371-A1 LIQUID CLEANING AND/OR CLEANSING COMPOSITION THE PROCTER & GAMBLE COMPANY 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170312190-A1 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES POLR1C, PLOD3, C9 LMNA 194/4885TSHR 3873/4885NFKB1 2522/4885
US-11160734-B2 Personal care compositions comprising shaped abrasive particles POLR1C, PLOD3, C9 LMNA 194/4885TSHR 3873/4885NFKB1 2522/4885
US-20110262371-A1 LIQUID CLEANING AND/OR CLEANSING COMPOSITION APOBEC3G, APOBEC3C, EXOSC9 LMNA 1746/4885TSHR 4324/4885NFKB1 3944/4885
US-20110262504-A1 LIQUID CLEANING AND/OR CLEANSING COMPOSITION APOBEC3G, APOBEC3C, EXOSC9 LMNA 1746/4885TSHR 4324/4885NFKB1 3944/4885
US-20130039961-A1 Personal Care Compositions Comprising Shaped Abrasive Particles POLR1C, PLOD3, C9 LMNA 194/4885TSHR 3873/4885NFKB1 2522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.